相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Polysulfated Xanthones: Multipathway Development of a New Generation of Dual Anticoagulant/Antiplatelet Agents
Marta Correia-da-Silva et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Flavonoids with an Oligopolysulfated Moiety A New Class of Anticoagulant Agents
Marta Correia-da-Silva et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Effects of Rutin and Hesperidin and their Al(III) and Cu(II) Complexes on in Vitro Plasma Coagulation Assays
Vesna Kuntic et al.
MOLECULES (2011)
Arterial thrombus formation in cardiovascular disease
Giuseppe Lippi et al.
NATURE REVIEWS CARDIOLOGY (2011)
Update on Antithrombotic Therapy New Anticoagulants
John W. Eikelboom et al.
CIRCULATION (2010)
Study of Physico-Chemical Properties of Novel Highly Sulfated, Aromatic, Mimetics of Heparin and Heparan Sulfate
Aiye Liang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Low-molecular-weight heparin-induced osteoporosis and osteoporotic fractures: A myth or an existing entity?
E. Lefkou et al.
LUPUS (2010)
A Series of Natural Flavonoids as Thrombin Inhibitors: Structure-activity relationships
Li Liu et al.
THROMBOSIS RESEARCH (2010)
First steps in the direction of synthetic, allosteric, direct inhibitors of thrombin and factor Xa
Jenson Verghese et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
On designing non-saccharide, allosteric activators of antithrombin
Arjun Raghuraman et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
Interaction of Antithrombin with Sulfated, Low Molecular Weight Lignins OPPORTUNITIES FOR POTENT, SELECTIVE MODULATION OF ANTITHROMBIN FUNCTION
Brian L. Henry et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Safety and efficacy of fondaparinux as an adjunctive treatment to thrombolysis in patients with high and intermediate risk pulmonary embolism
Sebastien Janin et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2009)
Lessons learned from the contamination of heparin
Haiying Liu et al.
NATURAL PRODUCT REPORTS (2009)
The Structure of Glycosaminoglycans and their Interactions with Proteins
Neha S. Gandhi et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2008)
Mechanisms of disease: Mechanisms of thrombus formation
Bruce Furie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Coagulation 2006: A modern view of hemostasis
Maureane Hoffman et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2007)
Oral, direct Factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseases
Alexander G. G. Turpie
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Novel chemo-enzymatic oligoiners of cinnainic acids as direct and-indirect inhibitors of coagulation proteinases
Bernhard H. Monien et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Mechanism of poly(acrylic acid) acceleration of antithrombin inhibition of thrombin: Implications for the design of novel heparin mimics
BH Monien et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Synthesis of per-sulfated flavonoids using 2,2,2-trichloro ethyl protecting group and their factor Xa inhibition potential
GT Gunnarsson et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
Antithrombin activation by nonsulfated, non-polysaccharide organic polymer
BH Monien et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Inhibitory effects of sulphated flavonoids isolated from Flaveria bidentis on platelet aggregation
HA Guglielmone et al.
THROMBOSIS RESEARCH (2005)
New antithrombin based anticoagulants
UR Desai
MEDICINAL RESEARCH REVIEWS (2004)
Sulfation of genistein alters its antioxidant properties and its effect on platelet aggregation and monocyte and endothelial function
G Rimbach et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2004)
Hydropathic interaction analyses of small organic activators binding to antithrombin
GT Gunnarsson et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next?
M Petitou et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2004)
Localization of an antithrombin exosite that promotes rapid inhibition of factors Xa and IXa dependent on heparin activation of the serpin
G Izaguirre et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
What is all that thrombin for?
KG Mann et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Antithrombin III phenylalanines 122 and 121 contribute to its high affinity for heparin and its conformational activation
MA Jairajpuri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Exploring new non-sugar sulfated molecules as activators of antithrombin
GT Gunnarsson et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Serpin structure, mechanism, and function
PGW Gettins
CHEMICAL REVIEWS (2002)
Interaction of designed sulfated flavanoids with antithrombin: Lessons on the design of organic activators
GT Gunnarsson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Identification of critical molecular interactions mediating heparin activation of antithrombin -: Implications for the design of improved heparin anticoagulants
ST Olson et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2002)
Heparin and heparan sulfate: structure and function
DL Rabenstein
NATURAL PRODUCT REPORTS (2002)
Designing small, nonsugar activators of antithrombin using hydropathic interaction analyses
GT Gunnarsson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Helix D elongation and allosteric activation of antithrombin
KJ Belzar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Anticoagulant effect and action mechanism of sulphated flavonoids from Flaveria bidentis
HA Guglielmone et al.
THROMBOSIS RESEARCH (2002)
Critical role of the linker region between helix D and strand 2A in heparin activation of antithrombin
JL Meagher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
An update on heparins at the beginning of the new millennium
J Fareed et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2000)
分享论文
